Managing Common Dermatoses in Skin of Color

Seminars in Cutaneous Medicine and Surgery

Volumn 28, Issue 2, 2009, Pages 63-70

  Coley, Marcelyn K ^a   Alexis, Andrew F ^a  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE; ANESTHETIC AGENT; ANTIINFECTIVE AGENT; AZELAIC ACID; BARIUM DERIVATIVE; BARIUM SULFIDE; BENZOYL PEROXIDE; CALCIUM DERIVATIVE; CLINDAMYCIN; CORTICOSTEROID; DESONIDE; EFLORNITHINE; ERYTHROMYCIN; GLYCOLIC ACID; HYDROQUINONE; KOJIC ACID; RETINOIC ACID; RETINOID; SALICYLIC ACID; SUNSCREEN; TAZAROTENE; THIOGLYCOLATE CALCIUM; UNCLASSIFIED DRUG;

ACNE; ACNE VULGARIS; CHLOASMA; CLINICAL FEATURE; DERMATOSIS PAPULOSA NIGRA; DRUG MECHANISM; ELECTROLYSIS; ELECTROSURGERY; EPITHELIUM TUMOR; HUMAN; HYPERKERATOSIS; HYPERPIGMENTATION; HYPERTROPHIC SCAR; INFLAMMATORY DISEASE; KELOID; LOW LEVEL LASER THERAPY; PATHOGENESIS; PATIENT COUNSELING; PATIENT EDUCATION; PSEUDOFOLLICULITIS BARBAE; REVIEW; SKIN COLOR; SKIN DISEASE; SOCIAL PSYCHOLOGY;

ACNE KELOID; ACNE VULGARIS; AFRICAN AMERICANS; BARBERING; FACIAL DERMATOSES; FOLLICULITIS; FOREIGN-BODY REACTION; HAIR REMOVAL; HUMANS; HYPERPIGMENTATION; SKIN DISEASES;

EID: 67650032983     PISSN: 10855629     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sder.2009.04.006     Document Type: Review

References (58)

1. Halder R.M., Grimes P.E., McLaurin C.I., et al. Incidence of common dermatoses in a predominantly black dermatologic practice. Cutis 32 (1983) 378-380
2. Alexis A.F., Sergay A.B., and Taylor S.C. Common dermatologic disorders in skin of color: A comparative practice survey. Cutis 80 (2007) 387-394
3. Taylor S.C. Epidemiology of skin diseases in ethnic populations. Dermatol Clin 21 (2003) 601-607
4. Child F.J., Fuller L.C., Higgins E.M., et al. A study of the spectrum of skin disease occurring in a black population in south-east London. Br J Dermatol 141 (1999) 512-517
5. Arsouze A., Fitoussi C., Cabotin P.P., et al. Presenting skin disorders in black afro-Caribbean patients: A multicenter study conducted in the Paris region. Ann Dermatol Venereol 135 (2008) 177-182
6. Dunwell P., and Rose A. Study of the skin disease spectrum occurring in an Afro-Caribbean population. Int J Dermatol 42 (2003) 287-289
7. Taylor S.C. Cosmetic problems in skin of color. Skin Pharmacol Appl Skin Physiol 12 (1999) 139-143
8. Taylor S.C., Cook-Bolden F., Rahman Z., et al. Acne vulgaris in skin of color. J Am Acad Dermatol 46 (2002) S98-S106
9. Grimes P.E. Pigmentary disorders in blacks. Dermatol Clin 6 (1988) 271
10. Taylor S.C. Skin of color: Biology, structure, function, and implications for dermatologic disease. J Am Acad Dermatol 46 suppl (2002) S41-S62
11. Halder R.M., Holmes Y.C., Bridgeman-Shah S., et al. A clinicopathological study of acne vulgaris in black females. J Invest Dermatol 106 (1996) 888
12. Halder R.M., Noothehi P.K., and Richards G.M. Dermatological disorders and cultural practices: Understanding practices that cause skin conditions in non-Caucasian populations. Skin Aging 10 (2002) 46-50
13. Laude T.A. Skin disorders in black children. Curr Opin Pediatr 8 (1996) 381-385
14. Callender V.D. Acne in ethnic skin: Special considerations for therapy. Dermatol Ther 17 (2004) 184-195
15. Halder R.M., Brooks H.L., and Caballero J.C. Common dermatological diseases in pigmented skins. In: Halder R.M. (Ed). Dermatology And Dermatological Therapy of Pigmented Skins (2006), Taylor & Francis, Boca Raton, FL 17-39
16. Leyden J.J. Topical treatment of acne vulgaris: Retinoids and cutaneous irritation. J Am Acad Dermatol 38 (1998) S1-S4
17. Halder R.M. The role of retinoids in the management of cutaneous conditions in blacks. J Am Acad Dermatol 39 suppl 2 (1998) S98-S103
18. Bulengo-Ransby S.M., Griffiths C., Kimbrough-Green C.K., et al. Topical tretinoin (retinoic acid) therapy for hyperpigmented lesions caused by inflammation of the skin in black patients. N Engl J Med 328 (1993) 1438-1443
19. Grimes P., and Callender V. Tazarotene cream for postinflammatory hyperpigmentation and acne vulgaris in darker skin: A double-blind, randomized, vehicle-controlled study. Cutis 77 (2006) 45-50
20. Czernielewski J., Poncet M., and Mizzi F. Efficacy and cutaneous safety of adapalene in black patients versus white patients with acne vulgaris. Cutis 70 (2002) 243-248
21. Zhu X.J., Tu P., Zhen J., et al. Adapalene gel 0.1%: Effective and well tolerated in the topical treatment of acne vulgaris in Chinese patients. Cutis 68 suppl 4 (2001) 55-59
22. Thiboutot D., Arsonnaud S., and Soto P. Efficacy and tolerability of adapalene 0.3% gel compared to tazarotene 0.1% gel in the treatment of acne vulgaris. J Drugs Dermatol 7 suppl 6 (2008) S3-S10
23. Jacyk W.K. Adapalene in the treatment of African patients. J Eur Acad Dermatol Venereol 15 suppl 3 (2001) 37-42
24. Leyden J.J. Current issues in antimicrobial therapy for the treatment of acne. J Eur Acad Dermatol Venereol 15 suppl 3 (2001) 51-55
25. Fitton A., and Goa K.L. Azelaic acid: A review of its pharmacological properties and therapeutic efficacy in acne and hyperpigmentary skin disorders. Drugs 41 (1991) 780-798
26. Hsu S., and Quan L.T. Topical antibacterial agents. In: Wolverton S.E. (Ed). Comprehensive Dermatologic Drug Therapy (2001), Saunders 473-496
27. Webster G. Combination azelaic acid therapy for acne vulgaris. J Am Acad Dermatol 43 (2000) 47-50
28. Roberts W.E. Chemical peeling in ethnic/dark skin. Dermatol Ther 17 (2004) 196-205
29. Burns R.L., Prevost-Blank P.L., Lawry M.A., et al. Glycolic acid peels for postinflammatory hyperpigmentation in black patients. A comparative study. Dermatol Surg 23 (1997) 171-174 discussion: 175
30. Grimes P.E. The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups. Dermatol Surg 25 (1999) 18-22
31. Cayce K.A., McMichael A.J., and Feldman S.R. Hyperpigmentation: An overview of the common afflictions. Dermatol Nurs 16 (2004) 401
32. Winter H., Schissel D., Parry D.A.D., et al. An unusual Ala12Thr polymorphism in the 1A alpha-helical segment of the companion layer-specific keratin K6hf: Evidence for a risk factor in the etiology of the common hair disorder psuedofolliculitis barbae. J Invest Dermatol 122 (2004) 652-657
33. Bridgeman-Shah S. The medical and surgical therapy of pseudofolliculitis barbae. Dermatol Ther 17 (2004) 158-163
34. Halder R.M., Roberts C.I., Nootheti P.K., et al. Dermatologic disease in blacks. In: Halder R.M. (Ed). Dermatology And Dermatological Therapy of Pigmented Skins (2006), Taylor & Francis, Boca Raton, FL 331-355
35. McMichael A.J. Hair and scalp disorders in ethnic populations. Dermatol Clin 21 (2003) 629-644
36. Perry P.K., Cook-Bolden F.E., Rahman Z., et al. Defining pseudofolliculitis barbae in 2001: A review of the literature and current trends. J Am Acad Dermatol 46 (2002) S113-S119
37. Quarles F.N., Brody H., Johnson B.A., et al. Pseudofolliculitis barbae. Dermatol Ther 20 (2007) 133-136
38. Strauss J.S., and Kligman A.M. Pseudofolliculitis of the beard. Arch Dermatol 74 (1956) 533-542
39. Alexander M.A. Evaluation of a foil-guarded shaver in the management of pseudofolliculitis barbae. Cutis 27 (1981) 534-537 540-542
40. Kelly A.P. Pseudofolliculitis barbae and acne keloidalis nuchae. Dermatol Clin 21 (2003) 645-653
41. Cook-Bolden F.E., Barba A., Halder R., et al. Twice-daily applications of benzoyl peroxide, 5%/clindamycin, 1% gel versus vehicle in the treatment of pseudofolliculitis barbae. Cutis 73 suppl 6 (2004) 18-24
42. Perricone N.V. Treatment of pseudofolliculitis barbae with topical glycolic acid: A report of two studies. Cutis 52 (1993) 232-235
43. Richards R.N., and Meharg G.E. Electrolysis: Observations from 13 years and 140,000 hours of experience. J Am Acad Dermatol 33 (1995) 662-666
44. Hage J.J., and Bouman F.G. Surgical depilation for the treatment of pseudofolliculitis or local hirsutism of the face: Experience in the first 40 patients. Plast Reconstr Surg 88 (1991) 446-451
45. Greppi I. Diode laser hair removal of the black patient. Lasers Surg Med 28 (2001) 150-155
46. Battle Jr. E.F., and Hobbs L.M. Laser-assisted hair removal for darker skin types. Dermatol Ther 17 (2004) 177-183
47. Weaver III S.M., and Sagaral E.C. Treatment of pseudofolliculitis barbae using the long-pulse Nd:YAG laser on skin types V and VI. Dermatol Surg 29 (2003) 1187-1191
48. Ross E.V., Cooke L.M., Timko A.L., et al. Treatment of pseudofolliculitis barbae in skin types IV, V, and VI with a long-pulsed neodymium:Yttrium aluminum garnet laser. J Am Acad Dermatol 47 (2002) 263-270
49. Schweiger E.S., Kwasniak L., and Aries D.J. Treatment of dermatosis papulosa nigra with a 1064 nm Nd:YAG laser: Report of two cases. J Cosmet Laser Ther 10 (2008) 120-122
50. Kauh Y.C., McDonald J.W., Rapaport J.A., et al. A surgical approach for dermatosis papulosa nigra. Int J Dermatol 22 (1983) 590-592
51. Grimes P.E., Arora S., Minus H.R., et al. Dermatosis papulosa nigra. Cutis 32 (1983) 385-386 392
52. Kwon O.S., Hwang E.J., Bae J.H., et al. Seborrheic keratosis in the Korean males: Causative role of sunlight. Photodermatology Photoimmunol Photomed 19 (2003) 73-80
53. Yeatman J.M., Kilkenny M., and Marks R. The prevalence of seborrheic keratoses in an Australian population: Does exposure to sunlight play a part in their frequency?. Br J Dermatol 137 (1997) 411-414
54. Niang S.O., Kane A., Diallo M., et al. Dermatosis papulosa nigra in Dakar, Senegal. Int J Dermatol 46 suppl 1 (2007) 45-47
55. Schwartz R.A. Sign of lesser-Trélat. J Am Acad Dermatol 35 (1996) 88-95
56. Schwartzberg J.B., Ricotti Jr. C.A., Ballard C.J., et al. Eruptive dermatosis papulosa nigra as a possible sign of internal malignancy. Int J Dermatol 46 (2007) 186-187
57. Carter E.L., Coppola C.A., and Barsanti F.A. A randomized, double-blind comparison of two topical anesthetic formulations prior to electrodesiccation of dermatosis papulosa nigra. Dermatol Surg 32 (2006) 1-6
58. Cockerell C.J., and Larsen F. Benign epidermal tumors and proliferations. In: Bolognia J.L., Lorizzo J.L., Rapini R.P., et al. (Eds). Dermatology (2008), Mosby/Elsevier, Spain 1661-1680 vol 2